Knockdown of lncRNA < em > HOXD-AS2 < /em > Improves the Prognosis of Glioma Patients by Inhibiting the Proliferation and Migration of Glioma Cells

CONCLUSION: HOXD-AS2 is an oncogenic lncRNA associated with the poor prognosis of glioma. Knockdown of HOXD-AS2 may reduce the growth of glioma, which may provide a new avenue for treatment.PMID:36408341 | PMC:PMC9668444 | DOI:10.1155/2022/9337647

Source: Evidence-based Complementary and Alternative Medicine - November 21, 2022 Category: Complementary Medicine Authors: Feng Chen Ru-Ru Zhao Qian Li Zhen-Hua Chen Chun Luo Source Type: research